Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 31;17(1):84.
doi: 10.1186/s12934-018-0929-4.

Module and individual domain deletions of NRPS to produce plipastatin derivatives in Bacillus subtilis

Affiliations

Module and individual domain deletions of NRPS to produce plipastatin derivatives in Bacillus subtilis

Ling Gao et al. Microb Cell Fact. .

Abstract

Background: Plipastatin, an antifungal lipopeptide, is synthesized by a non-ribosomal peptide synthetase (NRPS) in Bacillus subtilis. However, little information is available on the combinatorial biosynthesis strategies applied in plipastatin biosynthetic pathway. In this study, we applied module or individual domain deletion strategies to engineer the plipastatin biosynthetic pathway, and investigated the effect of deletions on the plipastatin assembly line, as well as revealed the synthetic patterns of novel lipopeptides.

Results: Module deletion inactivated the entire enzyme complex, whereas individual domain (A/T domain) deletion within module 7 truncated the assembly line, resulting in truncated linear hexapeptides (C16~17β-OHFA-Glu-Orn-Tyr-Thr-Glu-Ala/Val). Interestingly, within the module 6 catalytic unit, the effect of thiolation domain deletion differed from that of adenylation deletion. Absence of the T6-domain resulted in a nonproductive strain, whereas deletion of the A6-domain resulted in multiple assembly lines via module-skipping mechanism, generating three novel types of plipastatin derivatives, pentapeptides (C16~17β-OHFA-Glu-Orn-Tyr-Thr-Glu), hexapeptides (C16~17β-OHFA-Glu-Orn-Tyr-Thr-Glu-Ile), and octapeptides (C16~17β-OHFA-Glu-Orn-Tyr-Thr-Glu-Gln-Tyr-Ile).

Conclusions: Notably, a unique module-skipping process occurred following deletion of the A6-domain, which has not been previously reported for engineered NRPS systems. This finding provides new insight into the lipopeptides engineering. It is of significant importance for combinatorial approaches and should be taken into consideration in engineering non-ribosomal peptide biosynthetic pathways for generating novel lipopeptides.

Keywords: Genetic engineering; Module skipping; Novel lipopeptides; Plipastatin synthetase.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a Schematic diagram of the plipastatin biosynthetic system. b Structure of plipastatin. c Deletion strategies: (i) deleting module 6 or 7 in plipastatin NRPS respectively, (ii) Deleting single A6 or A7 domain, (iii) deleting single T6 and T7 domain. Plipastatin NRPS assembly line contains five subunits, encoded by five genes ppsABCDE. Base on their function, the plipastatin synthetase are divided into 10 modules. Each module is comprised of condensation (C), adenylation (A) and thiolation (T) domains. Module 2, 4, 6 and 9 contains an epimerization (E) domian. A thioesterase (Te) domain is located on the C-teminus of module 10, which is responsible for products cyclisation and hydrolysis
Fig. 2
Fig. 2
The high-resolution ESI-TOF–MS of hexapeptide ions with retention time (RT) 12.67–13.01 min produced by mutant strain BA7
Fig. 3
Fig. 3
ESI-MS/MS spectra of protonated hexapeptide ions [M + H]+ at m/z 980.5579 a and m/z 1008.5878 b, acquired in Quadrupole-TOF (Q-TOF) mass spectrometer of crude extract from mutant strain BA7
Fig. 4
Fig. 4
a LC–ESI–MS total chromatogram of crude extract from mutant strain BA6. b Chromatogram corresponding to m/z 1327.7401. c Chromatogram corresponding to m/z 923.5341. d Chromatogram corresponding to m/z 1036.6182. e High-resolution ESI–MS of parent ions from compound 1, 2 and 3
Fig. 5
Fig. 5
MS/MS analysis of octapeptide produced by mutant strain BA6. a The sequence of octapeptide and thirteen characteristic product ions b1 ~ b7 and y2 ~ y7. b MS/MS spectrum of octapeptide ion [M + H]+ at m/z 1327.7378 and assignment of key product ions
Fig. 6
Fig. 6
MS/MS analysis of pentapeptide produced by mutant strain BA6. a The sequence of pentapeptide and seven characteristic product ions b1 ~ b4 and y2 ~ y4. b MS/MS spectrum of pentapeptide ion [M + H]+ at m/z 923.5330 and assignment of key product ions
Fig. 7
Fig. 7
MS/MS analysis of hexapeptide produced by mutant strain BA6. a The sequence of hexapeptide and nine characteristic product ions b1 ~ b5 and y2 ~ y5. b MS/MS spectrum of hexapeptide ion [M + H]+ at m/z 1036.6172 and assignment of key product ions
Fig. 8
Fig. 8
An assumed mechanism involving module skipping for mutant plipastatin NRPS without A6 domain. a Formation of linear octapeptide by complete module 6 and 7 skipping. b Formation of linear hexapeptide by complete module 6, 7, 8 and 9 skipping. c Formation of linear pentapeptide by hydrolysis in advance of thioesterase (Te) domain

References

    1. Kumar A, Johri B. Antimicrobial lipopeptides of Bacillus: natural weapons for biocontrol of plant pathogens. In: Satyanarayana TJB, editor. Microorganisms in sustainable agriculture and biotechnology. Berlin: Springer; 2012. pp. 91–111.
    1. Baltz RH. Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat Biotechnol. 2006;24:1533–1540. doi: 10.1038/nbt1265. - DOI - PubMed
    1. Sieber SA, Marahiel MA. Learning from nature’s drug factories: nonribosomal synthesis of macrocyclic peptides. J Bacteriol. 2003;185:7036–7043. doi: 10.1128/JB.185.24.7036-7043.2003. - DOI - PMC - PubMed
    1. Grünewald J, Marahiel MA. Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides. Microbiol Mol Biol R. 2006;70:121–146. doi: 10.1128/MMBR.70.1.121-146.2006. - DOI - PMC - PubMed
    1. Sieber SA, Marahiel MA. Molecular mechanisms underlying nonribosomal peptide synthesis: approaches to new antibiotics. Chem Rev. 2005;105:715–738. doi: 10.1021/cr0301191. - DOI - PubMed

MeSH terms